Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While PT-141 is FDA-approved for treatment of hypoactive sexual desire disorder in premenopausal women and is studied for sexual dysfunction in other populations, increasing sexual desire via CNS melanocortin pathways42101, Tirzepatide is approved for type 2 diabetes and obesity, producing larger HbA1c and body-weight reductions than semaglutide in head-to-head trials24.
While PT-141 works as the synthetic melanocortin receptor agonist bremelanotide, an analog of α-MSH that activates central MC3R and MC4R to modulate neuronal circuits governing sexual desire and arousal3242101, Tirzepatide is a 39-amino-acid synthetic peptide primarily based on GIP sequence with C20 fatty diacid conjugation that acts as a dual agonist at GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite24.
PT-141
POMC
Tirzepatide
Not assigned in the current dataset.
PT-141 and Tirzepatide are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: PT-141 is more often discussed in the realm of Reproductive health, whereas Tirzepatide is more often associated with the realm of Metabolic and endocrine and Cardiovascular health. They also influence different molecular systems, with PT-141 tracking more closely to GPCR receptor while Tirzepatide centers more on GLP-1 receptor. Both are synthetic in origin. PT-141 takes the form of a cyclic peptide, whereas Tirzepatide is closer to a peptide conjugate, PT-141 carries acetylation features, while Tirzepatide instead reflects lipidation and d-amino acid substitution changes; while their sequence patterns also diverge, with PT-141 showing protein-mimetic sequence features and Tirzepatide showing alpha-helical domain features.